Results 31 to 40 of about 2,548 (213)

The future outlook on allergen immunotherapy in children: 2018 and beyond. [PDF]

, 2018
Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases.
Arasi S, Corsello G, Pajno GB, Villani A
core   +2 more sources

Practical issues of oral immunotherapy for egg or milk allergy [PDF]

Clinical and Experimental Pediatrics
Oral immunotherapy (OIT) has been recommended to reduce parental burden related to strict allergen avoidance and induce desensitization and immune tolerance for patients with long-lasting allergies to hen’s eggs (HE) or cow’s milk (CM).
Sukyung Kim, Kangmo Ahn, Jihyun Kim
doaj   +1 more source

Transitioning from epicutaneous to oral peanut immunotherapy

Frontiers in Allergy, 2023
IntroductionEpicutaneous immunotherapy (EPIT) has been tested in clinical trials for children with peanut allergy (PA) for its safety and efficacy in inducing desensitization.
Lauren Wong, Laurie Kost, Brent Anderson, Andrew Long, Sayantani B. Sindher, R. Sharon Chinthrajah, William J. Collins, William J. Collins   +7 more
doaj   +1 more source

Oral immunotherapy and anti-IgE antibody treatment for food allergy

World Allergy Organization Journal, 2015
Food allergy is a major public health problem affecting nearly 10 % of children in most industrialized countries. Unfortunately, there are no effective therapies for food allergy, relegating patients to simply avoid the offending foods and treat ...
Dale T. Umetsu, Rima Rachid, Lynda C. Schneider   +2 more
doaj   +1 more source

Risk factors associated with safety of preschool peanut oral immunotherapy

Journal of Allergy and Clinical Immunology: Global, 2023
Background: An understanding of how patient characteristics such as age, baseline peanut-specific IgE, and atopic comorbidities may influence potential safety outcomes during peanut oral immunotherapy (P-OIT) could aid in shared decision making between ...
Duva Karunakaran, BSc, Edmond S. Chan, MD, Qian Zhang, Jeffrey N. Bone, Stuart Carr, MD, Sandeep Kapur, MD, Gregory A. Rex, MD, Mary McHenry, MD, Scott B. Cameron, MD, PhD, Victoria E. Cook, MD, Sara Leo, MD, Tiffany Wong, MD, Thomas V. Gerstner, MD, Joanne Yeung, MD, Elissa M. Abrams, MD, Raymond Mak, MD, Stephanie C. Erdle, MD, Lianne Soller, PhD   +17 more
doaj   +1 more source

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy [PDF]

, 2014
BACKGROUND: Thirty percent of children with food allergy are allergic to more than one food. Previous studies on oral immunotherapy (OIT) for food allergy have focused on the administration of a single allergen at the time. This study aimed at evaluating
Alanna Blakemore, Anjuli Mehrotra, Anthony Trela, Bethany Kausch, Elisabeth Hoyte, Gerri O’Riordan, Kari C Nadeau, Liane Bacal, Lisa C Winterroth, Margie Woch, Philippe Bégin, Robert G Hamilton, Scott Seki, Shruti P Wilson, Tina Dominguez   +14 more
core   +1 more source

Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs : a blind, randomized, placebo-controlled study [PDF]

, 2017
Background: Food allergies are increasing in prevalence but no treatment strategies are currently available to cure dogs with food allergy. Over the past decade, experimental food allergen-specific sublingual immunotherapy (FA-SLIT) has emerged as a ...
Cox, Eric, Hesta, Myriam, Maina, Elisa, Pelst, Michael   +3 more
core   +2 more sources

Oral and sublingual immunotherapy for food allergy

World Allergy Organization Journal, 2014
IgE-mediated food allergy is a potentially life-threatening allergic disease with an increase in prevalence in developed countries over the past 15 years.
Uyenphuong H Le, A Wesley Burks
doaj   +1 more source

Efficacy, safety and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy [PDF]

, 2019
BACKGROUND: Only 2 small placebo-controlled trials on peanut oral immunotherapy (OIT) have been published. OBJECTIVE: We examined the efficacy, safety, immunologic parameters, quality of life (QOL), and burden of treatment (BOT) of low-dose peanut OIT
Ahrens, Frank, Beyer, Kirsten, Blumchen, Katharina, Gruebl, Armin, Hamelmann, Eckard, Hansen, Gesine, Hartmann, Oliver, Heinzmann, Andrea, Holzhauser, Thomas, Nemat, Katja, Niggemann, Bodo, Roeder, Martin, Rosenfeld, Leonard, Trendelenburg, Valérie   +13 more
core   +1 more source

Nationwide questionnaire-based survey of oral immunotherapy in Japan

Allergology International, 2018
Background: Clinical trials on oral immunotherapy (OIT) have been increasing for nearly a decade; however, several national guidelines do not recommend OIT as a standardized procedure. The aim of this study was to obtain insights into the current use and
Sakura Sato, Chizuko Sugizaki, Noriyuki Yanagida, Komei Ito, Yusei Ohshima, Naoki Shimojo, Takao Fujisawa, Motohiro Ebisawa   +7 more
doaj   +1 more source